Nader Makki is a Cardiology physician. OpenAlex indexes 18 publications with 324 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
500 W Thomas Rd Ste 850
Phoenix, AZ 850134218
Telephone
602-406-1150Provider last certified this registry record 15 Apr 2026.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year202510 payments
- CVRx, Inc.Program year20254 payments
- Boston Scientific CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.2%Beta blocker18.7%Carvedilol40%Metoprolol Succinate30%Metoprolol Tartrate18%Propranolol Hcl9%Atenolol2%Nebivolol Hcl2%Part D<11 patientsAdenosine Receptor Agonist11.8%Regadenoson100%Part B, office-administered≥188 patients+ 18 more classes in this area
Blood & clotting
16.6%Factor Xa inhibitor8.2%Eliquis80%Xarelto20%Part D≥116 patientsP2Y12 inhibitor7.7%Clopidogrel50%Prasugrel Hcl41%Brilinta9%Part D≥88 patients+ 1 more class in this area
Metabolism & gastrointestinal
4.6%Potassium supplement4.2%Potassium Chloride100%Part D≥108 patientsProton pump inhibitor0.4%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Advanced chronic kidney disease: Relationship to outcomes post‐TAVR, a meta‐analysis
Clinical Cardiology
2018 - A meta-analysis of reduced leaflet motion for surgical and transcatheter aortic valves: Relationship to cerebrovascular events and valve degeneration
Cardiovascular revascularization medicine
2018 - CRT-700.35 Slope of Left Ventricular Filling as an Index of Valvular and Paravalvular Regurgitation in Native and Prosthetic Aortic Valves
JACC: Cardiovascular Interventions
2018 - CRT-700.31 A Meta-analysis of Reduced Leaflet Motion: Relationship to Cerebrovascular Events and Valve Degeneration
JACC: Cardiovascular Interventions
2018 - Does Testosterone Therapy Increase Risk of Cardiovascular Events among Men? A Meta-analysis
Cardiology and Angiology An International Journal
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”